Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT Trial
Journal of the American Heart Association - United Kingdom
doi 10.1161/jaha.118.009664
Full Text
Open PDFAbstract
Available in full text
Date
November 6, 2018
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)